Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Geest, L.G.M. van der"'
Autor:
Reinders, M.T.M., Meer, S. van, Burgmans, M.C., Jong, K.P. de, Klumpen, H.J., Man, R.A. de, Ramsoekh, D., Sprengers, D., Tjwa, E.T.T.L., Vos-Geelen, J. de, Erpecum, K.J. van, Geest, L.G.M. van der, Dutch Hepatocellular & Cholangioca
Publikováno v:
European Journal of Cancer, 137, 214-223
European Journal of Cancer, 137, 214-223. ELSEVIER SCI LTD
European Journal of Cancer, 137, 214-223. Elsevier Limited
European Journal of Cancer, 137, 214-223. Elsevier Ltd.
European Journal of Cancer, 137, 214-223. Pergamon
European Journal of Cancer, 137, pp. 214-223
Reinders, M T M, van Meer, S, Burgmans, M C, de Jong, K P, Klümpen, H J, de Man, R A, Ramsoekh, D, Sprengers, D, Tjwa, E T T L, de Vos-Geelen, J, van Erpecum, K J, van der Geest, L G M & Dutch Hepatocellular & Cholangiocarcinoma Group (DHCG) 2020, ' Trends in incidence, diagnosis, treatment and survival of hepatocellular carcinoma in a low-incidence country : Data from the Netherlands in the period 2009–2016 ', European Journal of Cancer, vol. 137, pp. 214-223 . https://doi.org/10.1016/j.ejca.2020.07.008
European Journal of Cancer, 137, 214-223. ELSEVIER SCI LTD
European Journal of Cancer, 137, 214-223. Elsevier Limited
European Journal of Cancer, 137, 214-223. Elsevier Ltd.
European Journal of Cancer, 137, 214-223. Pergamon
European Journal of Cancer, 137, pp. 214-223
Reinders, M T M, van Meer, S, Burgmans, M C, de Jong, K P, Klümpen, H J, de Man, R A, Ramsoekh, D, Sprengers, D, Tjwa, E T T L, de Vos-Geelen, J, van Erpecum, K J, van der Geest, L G M & Dutch Hepatocellular & Cholangiocarcinoma Group (DHCG) 2020, ' Trends in incidence, diagnosis, treatment and survival of hepatocellular carcinoma in a low-incidence country : Data from the Netherlands in the period 2009–2016 ', European Journal of Cancer, vol. 137, pp. 214-223 . https://doi.org/10.1016/j.ejca.2020.07.008
Objective: Evaluation of the trends in incidence, diagnostics, treatment and survival of patients with hepatocellular carcinoma (HCC) in the Netherlands.Method: Data regarding incidence, diagnostics, primary treatment and survival of patients with HC
Autor:
Latenstein, A.E.J., Roessel, S. van, Geest, L.G.M. van der, Bonsing, B.A., Dejong, C.H.C., Koerkamp, B.G., Hingh, I.H.J.T. de, Horns, M.Y.V., Klaase, J.M., Lemmens, V., Molenaar, I.Q., Steyerberg, W., Stommel, M.W.J., Busch, O.R., Eijck, C.H.J. van, Laarhoven, H.W.M. van, Wilmink, J.W., Besselink, M.G., Dutch Pancreatic Canc Grp
Publikováno v:
Annals of Surgical Oncology, 27, 2516-2524
Annals of Surgical Oncology, 27(7), 2516-2524. Springer New York
Annals of Surgical Oncology
Annals of Surgical Oncology, 2516-2524. SPRINGER
ISSUE=7;STARTPAGE=2516;ENDPAGE=2524;ISSN=1068-9265;TITLE=Annals of Surgical Oncology
Annals of Surgical Oncology, 27, 2516-2524. SPRINGER
Annals of Surgical Oncology, 27, 7, pp. 2516-2524
Annals of Surgical Oncology, 27(7), 2516-2524. Springer, Cham
Annals of surgical oncology, 27(7), 2516-2524. Springer New York
Annals of Surgical Oncology, 27(7), 2516-2524. Springer New York
Annals of Surgical Oncology
Annals of Surgical Oncology, 2516-2524. SPRINGER
ISSUE=7;STARTPAGE=2516;ENDPAGE=2524;ISSN=1068-9265;TITLE=Annals of Surgical Oncology
Annals of Surgical Oncology, 27, 2516-2524. SPRINGER
Annals of Surgical Oncology, 27, 7, pp. 2516-2524
Annals of Surgical Oncology, 27(7), 2516-2524. Springer, Cham
Annals of surgical oncology, 27(7), 2516-2524. Springer New York
Background Conditional survival is the survival probability after already surviving a predefined time period. This may be informative during follow-up, especially when adjusted for tumor characteristics. Such prediction models for patients with resec
Autor:
Latenstein, A.E.J., Geest, L.G.M. van der, Bonsing, B.A., Koerkamp, B.G., Mohammad, N.H., Hingh, I.H.J.T. de, Meijer, V.E. de, Molenaar, I.Q., Santvoort, H.C. van, Tienhoven, G. van, Verheij, J., Vissers, P.A.J., Vos-Geelen, J. de, Busch, O.R., Eijck, C.H.J. van, Laarhoven, H.W.M. van, Besselink, M.G., Wilmink, J.W., Dutch Pancreatic Canc Grp
Publikováno v:
European Journal of Cancer, 125, 83-93. Elsevier Ltd.
European journal of cancer (Oxford, England, 125, 83-93. Elsevier Limited
European Journal of Cancer, 125, 83. Elsevier Limited
European Journal of Cancer, 125, 83-93. ELSEVIER SCI LTD
European journal of cancer (Oxford, England, 125, 83-93. Elsevier Limited
European Journal of Cancer, 125, 83. Elsevier Limited
European Journal of Cancer, 125, 83-93. ELSEVIER SCI LTD
Background: In recent years, new treatment options have become available for pancreatic ductal adenocarcinoma (PDAC) including 5-fluorouracil, leucovorin, irinotecan and oxaliplatin. The impact hereof has not been assessed in nationwide cohort studie
Autor:
Dekker, J.W.T., Gooiker, G.A., Bastiaannet, E., Broek, C.B.M. van den, Geest, L.G.M. van der, Velde, C.J. van de, Tollenaar, R.A.E.M., Liefers, G.J., Quality Information Syst Colorecta
Publikováno v:
EJSO-European Journal of Surgical Oncology, 40(11), 1481-1487
The 1-year mortality after colorectal cancer surgery is high and explains age related differences in colorectal cancer survival. To gain better insight in its etiology, cause of death for these patients was studied.All 1924 patients who had a resecti
Autor:
Dekker, J.W.T., Gooiker, G.A., Geest, L.G.M. van der, Kolfschoten, N.E., Struikmans, H., Putter, H., Wouters, M.W.J.M., Tollenaar, R.A.E.M., Quality Information Syst
Publikováno v:
EJSO, 38(11), 1071-1078
Aims Comorbidity affects outcomes after colorectal cancer surgery. However, it's importance in risk adjustment is unclear and different measures are being used. This study aims to assess its impact on post-operative outcomes. Methods All 2204 patient
Autor:
Geest, L.G.M. van der, Krijnen, P., Wouters, M.W.J.M., Erkelens, W.W., Marinelli, A.W.K.S., Nortier, H.W.R., Tollenaar, R.A.E.M., Struikmans, H., Comprehensive Canc Ctr Netherlands
Publikováno v:
Journal of Surgical Oncology, 106(1), 1-9
Background From 2006 to 2008, an audit of the multidisciplinary diagnosis and treatment of colorectal cancer patients in the western part of the Netherlands was carried out. We evaluated whether compliance with guidelines had improved. Methods All pa
Autor:
Erning, F.N. van, Mackay, T.M., Geest, L.G.M. van der, Koerkamp, B.G., Laarhoven, H.W.M. van, Bonsing, B.A., Wilmink, J.W., Santvoort, H.C. van, Vos-Geelen, J. de, Eijck, C.H.J. van, Busch, O.R., Lemmens, V.E., Besselink, M.G., Dutch Pancreatic Canc Grp
Publikováno v:
Acta Oncologica, 57(12), 1655-1662. TAYLOR & FRANCIS LTD
Acta oncologica (Stockholm, Sweden), 57(12), 1655-1622. Informa Healthcare
Acta Oncologica, 57(12), 1655-1662. Informa Healthcare
Acta Oncologica, 57(12), 1655-1662. Routledge/Taylor & Francis Group
Acta oncologica (Stockholm, Sweden), 57(12), 1655-1622. Informa Healthcare
Acta Oncologica, 57(12), 1655-1662. Informa Healthcare
Acta Oncologica, 57(12), 1655-1662. Routledge/Taylor & Francis Group
Background: The association between pancreatic ductal adenocarcinoma (PDAC) location (head, body, tail) and tumor stage, treatment and overall survival (OS) is unclear. Methods: Patients with PDAC diagnosed between 2005 and 2015 were included from th
Autor:
Extermann, M., Leede, N.M. de, Geest, L.G.M. van der, Egan, K., Craen, A.J.M. de, Springett, G.M., Velde, C.J.H. van de, Balducci, L., Bonsing, B.A., Bastiaannet, E.
Publikováno v:
Journal of Clinical Oncology, 33(15)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::8b78a058d4d4bf698f8d2684183e1b73
https://hdl.handle.net/1887/106824
https://hdl.handle.net/1887/106824
Autor:
Geest, L.G.M. van der, Portielje, J.E.A., Wouters, M.W.J.M., Weijl, N.I., Tanis, B.C., Tollenaar, R.A.E.M., Struikmans, H., Nortier, J.W.R., Nine Hosp Leiden Region Comprehens
Publikováno v:
Colorectal Disease, 15(10), e582-e591
Aim The study included investigation of factors determining suboptimal adjuvant chemotherapy of patients diagnosed with Stage III colon cancer. Method All 606 patients diagnosed with Stage III colon cancer between 2006 and 2008 in the western part of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25787767f0f005c9f6629e8637489c1a
https://hdl.handle.net/1887/100115
https://hdl.handle.net/1887/100115
Autor:
Geest, L.G.M. van der, Elferink, M.A.G., Steup, W.H., Witte, A.M.C., Nortier, J.W.R., Tollenaar, R.A.E.M., Struikmans, H.
Publikováno v:
European Journal of Cancer, 49, S518-S518
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::133a20814037049526ee1887ba34152f
http://hdl.handle.net/1887/100132
http://hdl.handle.net/1887/100132